Target intelligence / Profile preview

Skin-resident commensal microbiota

Molecular classification
Other
01

Overview

The skin-resident commensal microbiota is a complex ecosystem of bacteria, fungi, and viruses that colonize the human skin surface and its appendages. This community serves as a vital component of the skin's biological barrier, providing protection against pathogens through competitive exclusion and the secretion of antimicrobial peptides (Byrd et al., 2018, Nature Reviews Microbiology). It also plays a fundamental role in modulating the host's immune system, influencing both innate and adaptive responses to maintain cutaneous homeostasis (Belkaid & Segre, 2014, Science). Dysbiosis, or the disruption of this microbial balance, is strongly associated with the pathogenesis of chronic inflammatory conditions such as atopic dermatitis, acne vulgaris, and psoriasis (Kong et al., 2012, Genome Research). Therapeutic targeting of the skin microbiota involves the use of traditional antibiotics to reduce pathogen load, as well as novel biotherapeutic approaches including probiotics (live beneficial bacteria), prebiotics (substrates promoting beneficial growth), and postbiotics (metabolic byproducts) designed to restore a healthy microbial signature (Nakatsuji et al., 2017, Science Translational Medicine). These interventions aim to suppress pathogenic overgrowth while promoting the growth of beneficial commensals to improve skin health and barrier integrity.

Other names
Skin microbiomeCutaneous microbiotaSkin floraDermal microbiomeSkin microflora
02

Mechanism of action

Modulation of microbial community composition through competitive exclusion, production of antimicrobial peptides (AMPs), and regulation of host innate and adaptive inflammatory pathways.

03

Biological functions

Immune responseBarrier functionPathogen defenseMetabolismSignal transduction
04

Disease associations

Atopic dermatitisAcne vulgarisPsoriasisRosaceaInfectionWound healingSeborrheic dermatitis
05

Safety considerations

Risk of dysbiosisPotential for opportunistic infection in immunocompromised patientsDevelopment of antimicrobial resistanceInconsistent colonization efficiency of topically applied strainsPotential for horizontal gene transfer of virulence factors
06

Interacting drugs

Clindamycin

8 more in the full profile.

07

Biomarkers

Microbial diversity (Shannon index)Staphylococcus aureus relative abundanceCutibacterium acnes phylotype distributionSkin surface pHAntimicrobial peptide levels (e.g., Cathelicidin)

Beyond the preview

Go deeper on Skin-resident commensal microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin-resident commensal microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call